Sponge‐induced angiogenesis and inflammation in PAF receptor‐deficient mice (PAFR‐KO)
To determine biological functions of platelet‐activating factor (PAF) in chronic inflammation, we have investigated the kinetics of angiogenesis, inflammatory cells recruitment and cytokine production in sponge‐induced granuloma in wild type and PAF receptor‐deficient mice (PAFR‐KO). Angiogenesis as...
Saved in:
Published in | British journal of pharmacology Vol. 141; no. 7; pp. 1185 - 1192 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.04.2004
Nature Publishing |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | To determine biological functions of platelet‐activating factor (PAF) in chronic inflammation, we have investigated the kinetics of angiogenesis, inflammatory cells recruitment and cytokine production in sponge‐induced granuloma in wild type and PAF receptor‐deficient mice (PAFR‐KO).
Angiogenesis as determined by morphometric analysis and hemoglobin content was significantly higher in the implants of PAFR‐KO mice at all time points. Treatment with PAF receptor antagonist UK74505 (30 mg kg−1) also increased angiogenesis in sponge implants.
Neutrophils and macrophages accumulation, as determined by myeloperoxidase and N‐acetylglucosaminidase activities in the supernatant of implanted sponges were markedly decreased in PAFR‐KO mice. Surprisingly, the levels of the proinflammatory chemokines, keratinocyte‐derived chemokine and chemokine monocyte chemoattractant protein 1 were higher in the implants of the transgenic animals.
We have shown that angiogenesis was stimulated in PAFR‐KO mice whereas inflammation was decreased, indicating that PAF is an endogenous regulator of new blood vessels formation in the inflammatory microenvironment induced by the sponge implant.
British Journal of Pharmacology (2004) 141, 1185–1192. doi:10.1038/sj.bjp.0705731 |
---|---|
AbstractList | 1. To determine biological functions of platelet-activating factor (PAF) in chronic inflammation, we have investigated the kinetics of angiogenesis, inflammatory cells recruitment and cytokine production in sponge-induced granuloma in wild type and PAF receptor-deficient mice (PAFR-KO). 2. Angiogenesis as determined by morphometric analysis and hemoglobin content was significantly higher in the implants of PAFR-KO mice at all time points. Treatment with PAF receptor antagonist UK74505 (30 mg kg(-1)) also increased angiogenesis in sponge implants. 3. Neutrophils and macrophages accumulation, as determined by myeloperoxidase and N-acetylglucosaminidase activities in the supernatant of implanted sponges were markedly decreased in PAFR-KO mice. Surprisingly, the levels of the proinflammatory chemokines, keratinocyte-derived chemokine and chemokine monocyte chemoattractant protein 1 were higher in the implants of the transgenic animals. 4. We have shown that angiogenesis was stimulated in PAFR-KO mice whereas inflammation was decreased, indicating that PAF is an endogenous regulator of new blood vessels formation in the inflammatory microenvironment induced by the sponge implant.1. To determine biological functions of platelet-activating factor (PAF) in chronic inflammation, we have investigated the kinetics of angiogenesis, inflammatory cells recruitment and cytokine production in sponge-induced granuloma in wild type and PAF receptor-deficient mice (PAFR-KO). 2. Angiogenesis as determined by morphometric analysis and hemoglobin content was significantly higher in the implants of PAFR-KO mice at all time points. Treatment with PAF receptor antagonist UK74505 (30 mg kg(-1)) also increased angiogenesis in sponge implants. 3. Neutrophils and macrophages accumulation, as determined by myeloperoxidase and N-acetylglucosaminidase activities in the supernatant of implanted sponges were markedly decreased in PAFR-KO mice. Surprisingly, the levels of the proinflammatory chemokines, keratinocyte-derived chemokine and chemokine monocyte chemoattractant protein 1 were higher in the implants of the transgenic animals. 4. We have shown that angiogenesis was stimulated in PAFR-KO mice whereas inflammation was decreased, indicating that PAF is an endogenous regulator of new blood vessels formation in the inflammatory microenvironment induced by the sponge implant. To determine biological functions of platelet‐activating factor (PAF) in chronic inflammation, we have investigated the kinetics of angiogenesis, inflammatory cells recruitment and cytokine production in sponge‐induced granuloma in wild type and PAF receptor‐deficient mice (PAFR‐KO). Angiogenesis as determined by morphometric analysis and hemoglobin content was significantly higher in the implants of PAFR‐KO mice at all time points. Treatment with PAF receptor antagonist UK74505 (30 mg kg −1 ) also increased angiogenesis in sponge implants. Neutrophils and macrophages accumulation, as determined by myeloperoxidase and N ‐acetylglucosaminidase activities in the supernatant of implanted sponges were markedly decreased in PAFR‐KO mice. Surprisingly, the levels of the proinflammatory chemokines, keratinocyte‐derived chemokine and chemokine monocyte chemoattractant protein 1 were higher in the implants of the transgenic animals. We have shown that angiogenesis was stimulated in PAFR‐KO mice whereas inflammation was decreased, indicating that PAF is an endogenous regulator of new blood vessels formation in the inflammatory microenvironment induced by the sponge implant. British Journal of Pharmacology (2004) 141 , 1185–1192. doi: 10.1038/sj.bjp.0705731 1. To determine biological functions of platelet-activating factor (PAF) in chronic inflammation, we have investigated the kinetics of angiogenesis, inflammatory cells recruitment and cytokine production in sponge-induced granuloma in wild type and PAF receptor-deficient mice (PAFR-KO). 2. Angiogenesis as determined by morphometric analysis and hemoglobin content was significantly higher in the implants of PAFR-KO mice at all time points. Treatment with PAF receptor antagonist UK74505 (30 mg kg(-1)) also increased angiogenesis in sponge implants. 3. Neutrophils and macrophages accumulation, as determined by myeloperoxidase and N-acetylglucosaminidase activities in the supernatant of implanted sponges were markedly decreased in PAFR-KO mice. Surprisingly, the levels of the proinflammatory chemokines, keratinocyte-derived chemokine and chemokine monocyte chemoattractant protein 1 were higher in the implants of the transgenic animals. 4. We have shown that angiogenesis was stimulated in PAFR-KO mice whereas inflammation was decreased, indicating that PAF is an endogenous regulator of new blood vessels formation in the inflammatory microenvironment induced by the sponge implant. To determine biological functions of platelet‐activating factor (PAF) in chronic inflammation, we have investigated the kinetics of angiogenesis, inflammatory cells recruitment and cytokine production in sponge‐induced granuloma in wild type and PAF receptor‐deficient mice (PAFR‐KO). Angiogenesis as determined by morphometric analysis and hemoglobin content was significantly higher in the implants of PAFR‐KO mice at all time points. Treatment with PAF receptor antagonist UK74505 (30 mg kg−1) also increased angiogenesis in sponge implants. Neutrophils and macrophages accumulation, as determined by myeloperoxidase and N‐acetylglucosaminidase activities in the supernatant of implanted sponges were markedly decreased in PAFR‐KO mice. Surprisingly, the levels of the proinflammatory chemokines, keratinocyte‐derived chemokine and chemokine monocyte chemoattractant protein 1 were higher in the implants of the transgenic animals. We have shown that angiogenesis was stimulated in PAFR‐KO mice whereas inflammation was decreased, indicating that PAF is an endogenous regulator of new blood vessels formation in the inflammatory microenvironment induced by the sponge implant. British Journal of Pharmacology (2004) 141, 1185–1192. doi:10.1038/sj.bjp.0705731 To determine biological functions of platelet-activating factor (PAF) in chronic inflammation, we have investigated the kinetics of angiogenesis, inflammatory cells recruitment and cytokine production in sponge-induced granuloma in wild type and PAF receptor-deficient mice (PAFR-KO). Angiogenesis as determined by morphometric analysis and hemoglobin content was significantly higher in the implants of PAFR-KO mice at all time points. Treatment with PAF receptor antagonist UK74505 (30 mg kg −1 ) also increased angiogenesis in sponge implants. Neutrophils and macrophages accumulation, as determined by myeloperoxidase and N -acetylglucosaminidase activities in the supernatant of implanted sponges were markedly decreased in PAFR-KO mice. Surprisingly, the levels of the proinflammatory chemokines, keratinocyte-derived chemokine and chemokine monocyte chemoattractant protein 1 were higher in the implants of the transgenic animals. We have shown that angiogenesis was stimulated in PAFR-KO mice whereas inflammation was decreased, indicating that PAF is an endogenous regulator of new blood vessels formation in the inflammatory microenvironment induced by the sponge implant. |
Author | Barcelos, Lucíola S Teixeira, Mauro M Vasconcelos, Anilton C Campos, Paula P Ferreira, Mônica A N D Andrade, Silvia P |
AuthorAffiliation | 3 3 Physiology and Biophysics, Institute of Biological Sciences, Federal University of Minas Gerais, Brazil 2 2 Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Brazil 1 1 Departments of General Pathology, Institute of Biological Sciences, Federal University of Minas Gerais, Brazil |
AuthorAffiliation_xml | – name: 1 1 Departments of General Pathology, Institute of Biological Sciences, Federal University of Minas Gerais, Brazil – name: 3 3 Physiology and Biophysics, Institute of Biological Sciences, Federal University of Minas Gerais, Brazil – name: 2 2 Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Brazil |
Author_xml | – sequence: 1 givenname: Mônica A N D surname: Ferreira fullname: Ferreira, Mônica A N D – sequence: 2 givenname: Lucíola S surname: Barcelos fullname: Barcelos, Lucíola S – sequence: 3 givenname: Paula P surname: Campos fullname: Campos, Paula P – sequence: 4 givenname: Anilton C surname: Vasconcelos fullname: Vasconcelos, Anilton C – sequence: 5 givenname: Mauro M surname: Teixeira fullname: Teixeira, Mauro M – sequence: 6 givenname: Silvia P surname: Andrade fullname: Andrade, Silvia P |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15678589$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/15023865$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU1v1DAQhi1URLeFK0cUIYHoIYsdx7FzQSoVbRGVWvFx4mA5k8niKLFTewPqjZ_Ab-SX4LILlEqIkzUzzzsffvfIjvMOCXnI6JJRrp7Hftn005JKKiRnd8iClbLKBVdshywopTJnTKldshdjT2kqSnGP7DJBC64qsSAf303erfD712_WtTNgmxm3sn6FDqONKWgz67rBjKNZW-9SkF0cHmcBAae1D0nXYmfBoltnowXMnqXy25R-c35wn9ztzBDxwfbdJx-OX70_Os3Pzk9eHx2e5SAEF7kqQWBtZFHICroCWQNG1C2UVdkabBQDw4E3KVMIaIVsgNaClRUik61E4PvkxabvNDcjtpB2CWbQU7CjCVfaG6v_rjj7Sa_8Z82ELFVdpgZPtw2Cv5wxrvVoI-AwGId-jloyWdesqBP4-BbY-zm4dJwumGQ1L8oiQY9urvN7j1-fnoAnW8BEMEMXjAMbb3CVVEJdT1tuOAg-xoDdH4Tqa_d17HVyX2_dT4LylgDs-qdv6Ww7_FvGN7IvdsCr_wzRLy9Oyypd8QOaQcgg |
CODEN | BJPCBM |
CitedBy_id | crossref_primary_10_1080_10739680500253535 crossref_primary_10_2353_ajpath_2006_050634 crossref_primary_10_1111_j_1476_5381_2011_01566_x crossref_primary_10_1177_1933719111428518 crossref_primary_10_1016_j_bionut_2011_06_014 crossref_primary_10_1016_j_bcp_2017_01_008 crossref_primary_10_1016_j_biopha_2018_09_042 crossref_primary_10_1128_AAC_00764_17 crossref_primary_10_1258_ebm_2012_012066 crossref_primary_10_1016_j_mvr_2014_07_002 crossref_primary_10_23868_gc120518 crossref_primary_10_3390_ijms19103109 crossref_primary_10_1007_s00011_013_0638_8 crossref_primary_10_1016_j_ijbiomac_2019_08_171 crossref_primary_10_1590_0001_3765201378011 crossref_primary_10_1016_j_lfs_2007_05_003 crossref_primary_10_1007_s10534_011_9481_y crossref_primary_10_1097_00075197_200503000_00004 crossref_primary_10_3390_vaccines12121322 crossref_primary_10_1016_j_biopha_2009_08_004 crossref_primary_10_1016_j_colsurfb_2015_09_005 crossref_primary_10_1038_s41423_020_0412_0 crossref_primary_10_15392_2319_0612_2024_2490 crossref_primary_10_1016_j_mvr_2011_08_002 crossref_primary_10_1254_jphs_13073FP crossref_primary_10_1016_j_biopha_2016_11_146 crossref_primary_10_1002_jbm_b_30810 crossref_primary_10_1016_j_lfs_2005_07_040 crossref_primary_10_1016_j_mvr_2009_04_009 crossref_primary_10_1016_j_mvr_2014_02_011 crossref_primary_10_1111_j_1524_475X_2008_00381_x crossref_primary_10_1371_journal_pone_0110945 crossref_primary_10_1111_j_1365_2613_2008_00633_x crossref_primary_10_1038_sj_bjp_0706327 |
Cites_doi | 10.1007/978-3-0348-9006-9_10 10.1182/blood.V90.3.909 10.1172/JCI9621 10.1073/pnas.84.15.5277 10.1006/mvre.1997.2047 10.1074/jbc.272.36.22898 10.1084/jem.184.1.191 10.1016/S0005-2760(98)00012-5 10.1016/0002-9394(78)90289-1 10.4049/jimmunol.169.11.6474 10.1161/01.ATV.20.1.80 10.4049/jimmunol.154.12.6492 10.1038/sj.bjp.0703756 10.1006/mvre.1999.2217 10.1016/0014-2999(94)90068-X 10.1172/JCI118142 10.1152/ajpregu.2001.280.4.R994 10.1093/carcin/14.7.1289 10.1016/S0167-0115(02)00070-8 10.1016/S0163-7827(99)00016-8 10.4049/jimmunol.168.11.5798 10.1084/jem.187.11.1779 10.1007/s00705-002-0903-6 10.1001/archsurg.1989.01410120068014 10.1096/fasebj.11.6.9194526 10.1038/nm0195-27 10.1074/jbc.270.14.7787 10.1016/S0022-2275(20)39691-7 10.1016/0006-291X(89)90032-6 10.1152/physrev.2000.80.4.1669 |
ContentType | Journal Article |
Copyright | 2004 British Pharmacological Society 2004 INIST-CNRS Copyright Nature Publishing Group Apr 2004 Copyright 2004, Nature Publishing Group 2004 Nature Publishing Group |
Copyright_xml | – notice: 2004 British Pharmacological Society – notice: 2004 INIST-CNRS – notice: Copyright Nature Publishing Group Apr 2004 – notice: Copyright 2004, Nature Publishing Group 2004 Nature Publishing Group |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7QP 7RV 7TK 7X7 7XB 88E 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.1038/sj.bjp.0705731 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Nursing & Allied Health Database Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Database ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection ProQuest Health & Medical Collection Medical Database Biological Science Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE ProQuest Central Student |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1476-5381 |
EndPage | 1192 |
ExternalDocumentID | PMC1574894 984045431 15023865 15678589 10_1038_sj_bjp_0705731 BPH4665 |
Genre | article Research Support, Non-U.S. Gov't Journal Article Comparative Study |
GroupedDBID | --- .3N .55 .GJ 05W 0R~ 1OC 23N 24P 2WC 31~ 33P 36B 3O- 3SF 3V. 4.4 52U 52V 53G 5GY 6J9 7RV 7X7 8-0 8-1 88E 8AO 8FE 8FH 8FI 8FJ 8R4 8R5 8UM A00 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCUV ABDBF ABPVW ABQWH ABUWG ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACUHS ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFKRA AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB AOIJS ATUGU AZBYB AZVAB B0M BAFTC BAWUL BBNVY BENPR BFHJK BHBCM BHPHI BKEYQ BMXJE BPHCQ BRXPI BVXVI C45 CAG CCPQU COF CS3 DCZOG DIK DRFUL DRMAN DRSTM DU5 E3Z EAD EAP EAS EBC EBD EBS ECV EJD EMB EMK EMOBN ENC ESX EX3 F5P FUBAC FYUFA G-S GODZA GX1 H.X HCIFZ HGLYW HMCUK HYE HZ~ J5H KBYEO LATKE LEEKS LH4 LITHE LK8 LOXES LSO LUTES LW6 LYRES M1P M7P MEWTI MK0 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ N9A NAPCQ NF~ O66 O9- OIG OK1 OVD P2P P2W P4E PQQKQ PROAC PSQYO Q.N Q2X QB0 RIG ROL RPM RWI SJN SUPJJ SV3 TEORI TR2 TUS UKHRP UPT WBKPD WH7 WHWMO WIH WIJ WIK WIN WOHZO WOW WVDHM WXSBR X7M XV2 Y6R YHG ZGI ZXP ZZTAW ~8M ~S- AAFWJ AAYXX AEYWJ AGYGG CITATION AAMMB AEFGJ AGHNM AGXDD AIDQK AIDYY IQODW PHGZM PHGZT PJZUB PPXIY PQGLB CGR CUY CVF ECM EIF NPM 7QP 7TK 7XB 8FK AZQEC DWQXO GNUQQ K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c5535-84c5e9a72276cf2e1bca59dc464daeb81ca3c3b9dc25cd57bc095146ee17d7ec3 |
IEDL.DBID | 7X7 |
ISSN | 0007-1188 |
IngestDate | Thu Aug 21 14:04:30 EDT 2025 Tue Aug 05 10:07:43 EDT 2025 Fri Jul 25 19:18:09 EDT 2025 Mon Jul 21 05:59:02 EDT 2025 Mon Jul 21 09:11:25 EDT 2025 Tue Jul 01 00:53:08 EDT 2025 Thu Apr 24 23:03:29 EDT 2025 Wed Jan 22 17:02:45 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | Implant growth factors Animal origin Inflammation chemokines Platelet-activating factor receptor Chemokine Marine environment Angiogenesis Porifera Knockout mouse sponge implants Neovascularization Invertebrata Growth factor |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5535-84c5e9a72276cf2e1bca59dc464daeb81ca3c3b9dc25cd57bc095146ee17d7ec3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0705731 |
PMID | 15023865 |
PQID | 217193242 |
PQPubID | 42104 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_1574894 proquest_miscellaneous_71799129 proquest_journals_217193242 pubmed_primary_15023865 pascalfrancis_primary_15678589 crossref_primary_10_1038_sj_bjp_0705731 crossref_citationtrail_10_1038_sj_bjp_0705731 wiley_primary_10_1038_sj_bjp_0705731_BPH4665 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | April 2004 |
PublicationDateYYYYMMDD | 2004-04-01 |
PublicationDate_xml | – month: 04 year: 2004 text: April 2004 |
PublicationDecade | 2000 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: Basingstoke – name: England – name: London |
PublicationTitle | British journal of pharmacology |
PublicationTitleAlternate | Br J Pharmacol |
PublicationYear | 2004 |
Publisher | Blackwell Publishing Ltd Nature Publishing |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Nature Publishing |
References | 1995; 96 1995; 72 1994; 258 1991; 34 1997; 272 1989; 159 2001; 280 2000b; 20 1996; 184 1932; 98 1998; 1392 2000; 131 1988; 162 1995; 154 1995; 1 1995; 270 1992; 73 1993; 14 1997; 90 1993; 34 1987; 84 2000; 39 1997; 11 1997; 54 1989; 124 2000; 59 1978; 86 2000; 105 2002; 168 2002; 169 1997; 79 2000; 52 2002; 107 2003; 148 1998; 187 1992; 67 2000a; 80 1994; 10 e_1_2_7_6_1 e_1_2_7_3_1 ANDRADE S.P. (e_1_2_7_4_1) 1992; 73 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 GRIFFIOEN A.W. (e_1_2_7_15_1) 2000; 52 HU D.E. (e_1_2_7_16_1) 1995; 72 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_14_1 e_1_2_7_13_1 e_1_2_7_12_1 e_1_2_7_26_1 e_1_2_7_27_1 e_1_2_7_28_1 e_1_2_7_29_1 CAMUSSI G. (e_1_2_7_10_1) 1995; 154 BAILEY P.J. (e_1_2_7_5_1) 1988; 162 DRABKIN D.L. (e_1_2_7_11_1) 1932; 98 e_1_2_7_25_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_23_1 PARRY M.J. (e_1_2_7_30_1) 1994; 10 e_1_2_7_33_1 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_37_1 e_1_2_7_38_1 e_1_2_7_39_1 ALABASTER V.A. (e_1_2_7_2_1) 1991; 34 PASSANITI A. (e_1_2_7_31_1) 1992; 67 15023858 - Br J Pharmacol. 2004 Apr;141(7):1085-6. doi: 10.1038/sj.bjp.0705728 |
References_xml | – volume: 162 start-page: 327 year: 1988 end-page: 334 article-title: Sponge implants as models publication-title: Method Immunol. – volume: 96 start-page: 940 year: 1995 end-page: 952 article-title: Platelet activating factor produced by Kaposi's sarcoma cells induces and sustains angiogenesis publication-title: J. Clin. Invest. – volume: 154 start-page: 6492 year: 1995 end-page: 6501 article-title: Platelet activating factor directly stimulates migration of endothelial cells and promotes angiogenesis by a heparin‐dependent mechanism publication-title: J. Immunol. – volume: 168 start-page: 5798 issue: Suppl. 11 year: 2002 end-page: 5804 article-title: Generation of biologically active angiostatin kringle 1‐3 by activated human neutrophils publication-title: J. Immunol. – volume: 1392 start-page: 145 year: 1998 end-page: 152 article-title: The role of platelet activating factor and other lipid mediators in inflammatory angiogenesis publication-title: Biochem. Biophy. Acta – volume: 131 start-page: 1800 year: 2000 end-page: 1808 article-title: Effects of the PAF receptor antagonist UK74505 on local and remote reperfusion injuries following ischaemia of the superior mesenteric artery in the rat publication-title: Br. J. Pharmacol. – volume: 10 start-page: 251 year: 1994 end-page: 268 article-title: Pharmacological profile of UK‐74,505, a novel and selective PAF antagonist with potent and prolonged oral activity publication-title: J. Lipid Mediat. Cell Signal. – volume: 34 start-page: 221 year: 1991 end-page: 227 article-title: UK74505, a novel and selective PAF antagonist, exhibits potent and long lasting activity publication-title: Agents Actions (Suppl.) – volume: 98 start-page: 719 year: 1932 end-page: 733 article-title: Spectrophotometric constants common hemoglobin derivatives in human, dog, and rabbit blood publication-title: J. Biol. Chem. – volume: 14 start-page: 1289 year: 1993 end-page: 1296 article-title: Platelet activating factor, an endogenous mediator of inflammation, induces phenotypic transformation of rat embryo cells publication-title: Carcinogenesis – volume: 258 start-page: 151 year: 1994 end-page: 154 article-title: Leukotrienes C4 and D4 promote angiogenesis a receptor‐mediated interaction publication-title: Eur. J. Pharmacol. – volume: 90 start-page: 909 year: 1997 end-page: 928 article-title: Chemokines publication-title: Blood – volume: 184 start-page: 191 year: 1996 end-page: 201 article-title: Platelet‐activating factor exerts mitogenic activity and stimulates expression of interleukin 6 and interleukin 8 in human lung fibroblasts binding to its functional receptor publication-title: J. Exp. Med. – volume: 73 start-page: 503 year: 1992 end-page: 513 article-title: Effects of platelet activating factor (PAF) and other vasoconstrictors on a model of angiogenesis in the mouse publication-title: Int. J. Exp. Pathol. – volume: 39 start-page: 41 year: 2000 end-page: 82 article-title: Platelet‐activating factor (PAF) and genetically engineered PAF receptor mutant mice publication-title: Prog. Lipid Res. – volume: 159 start-page: 572 year: 1989 end-page: 578 article-title: Leukotriene C4 stimulates angiogenesis in bovine carotid artery endothelial cells publication-title: Biochem. Biophys. Res. Commun. – volume: 67 start-page: 519 year: 1992 end-page: 528 article-title: A simple, quantitative method for assessing angiogenesis and antiangiogenesis agents using reconstituted basement membrane, heparin and fibroblast growth factor publication-title: Lab. Invest. – volume: 86 start-page: 455 year: 1978 end-page: 461 article-title: Neovasculogenic ability of prostaglandins, growth factors and synthetic chemoattractants publication-title: Am. J. Ophthalmol. – volume: 59 start-page: 278 year: 2000 end-page: 285 article-title: Assessment of angiogenesis and tumor growth in conscious mice by a fluorimetric method publication-title: Microvasc. Res. – volume: 280 start-page: R994 year: 2001 end-page: R1000 article-title: Mechanisms of angiotensin‐(1‐7)‐induced inhibition of angiogenesis publication-title: Am. J. Physiol. Regul. Integ. Comp. Physiol. – volume: 84 start-page: 5277 year: 1987 end-page: 5281 article-title: Tumor necrosis factor type , a potent inhibitor of endothelial cell growth , is angiogenic publication-title: Proc. Natl. Acad. Sci. U.S.A. – volume: 169 start-page: 6474 year: 2002 end-page: 6481 article-title: Proinflammatory gene induction by platelet‐activating factor mediated its cognate nuclear receptor publication-title: J. Immunol. – volume: 54 start-page: 253 year: 1997 end-page: 261 article-title: Sponge‐induced angiogenesis in mice and the pharmacological reactivity of the neovasculature quantitated by a fluorimetric method publication-title: Microvasc. Res. – volume: 80 start-page: 1669 year: 2000a end-page: 1699 article-title: Role of platelet‐activating factor in cardiovascular pathophysiology publication-title: Physiol. Rev. – volume: 124 start-page: 1422 year: 1989 end-page: 1428 article-title: Characterization of wound cytokines in the sponge matrix model publication-title: Arch. Surg. – volume: 20 start-page: 80 year: 2000b end-page: 88 article-title: Platelet‐activating factor enhances VEGF‐induced endothelial cell motility and neo‐angiogenesis in a murine matrigel model publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 270 start-page: 7787 year: 1995 end-page: 7790 article-title: Platelet activating factor stimulates transcription of the heparin‐binding epidermal growth factor‐like growth factor in monocytes publication-title: J. Biol. Chem. – volume: 1 start-page: 27 year: 1995 end-page: 31 article-title: Angiogenesis in cancer, vascular, rheumatoid and other diseases publication-title: Nat Med. – volume: 148 start-page: 153 year: 2003 end-page: 164 article-title: Apoptosis in canine distemper publication-title: Arch. Virol. – volume: 11 start-page: 457 year: 1997 end-page: 465 article-title: The codependence of angiogenesis and chronic inflammation publication-title: FASEB J. – volume: 79 start-page: 233 year: 1997 end-page: 269 article-title: Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine publication-title: Experientia Supplementum (Basel) – volume: 187 start-page: 1779 year: 1998 end-page: 1788 article-title: Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet‐activating factor receptor publication-title: J. Exp. Med. – volume: 52 start-page: 237 year: 2000 end-page: 268 article-title: Angiogenesis: potentials for pharmacological intervention in the treatment of cancer, cardiovascular diseases and chronic inflammation publication-title: Pharmacol. Rev. – volume: 34 start-page: 691 year: 1993 end-page: 702 article-title: Platelet‐activating factor: a phospholipid autacoid with diverse actions publication-title: J. Lipid Res. – volume: 105 start-page: 1589 year: 2000 end-page: 1594 article-title: Host cyclooxygenase‐2 modulates carcinoma growth publication-title: J. Clin. Invest. – volume: 272 start-page: 22898 year: 1997 end-page: 22904 article-title: Platelet activating factor (PAF) induces growth stimulation, inhibition, and suppression of oncogenic transformation in NRK cells overexpressing the PAF receptor publication-title: J. Biol. Chem. – volume: 72 start-page: 601 year: 1995 end-page: 610 article-title: Correlation of 133Xe clearance, blood flow and histology in the rat sponge model for angiogenesis publication-title: Lab. Invest. – volume: 107 start-page: 105 year: 2002 end-page: 113 article-title: Vasodilator effect of angiotensin‐(1‐7) in mature and sponge‐induced neovasculature publication-title: Regul Peptides – ident: e_1_2_7_8_1 doi: 10.1007/978-3-0348-9006-9_10 – ident: e_1_2_7_32_1 doi: 10.1182/blood.V90.3.909 – ident: e_1_2_7_38_1 doi: 10.1172/JCI9621 – ident: e_1_2_7_12_1 doi: 10.1073/pnas.84.15.5277 – ident: e_1_2_7_3_1 doi: 10.1006/mvre.1997.2047 – ident: e_1_2_7_22_1 doi: 10.1074/jbc.272.36.22898 – ident: e_1_2_7_33_1 doi: 10.1084/jem.184.1.191 – volume: 52 start-page: 237 year: 2000 ident: e_1_2_7_15_1 article-title: Angiogenesis: potentials for pharmacological intervention in the treatment of cancer, cardiovascular diseases and chronic inflammation publication-title: Pharmacol. Rev. – ident: e_1_2_7_19_1 doi: 10.1016/S0005-2760(98)00012-5 – ident: e_1_2_7_6_1 doi: 10.1016/0002-9394(78)90289-1 – ident: e_1_2_7_26_1 doi: 10.4049/jimmunol.169.11.6474 – ident: e_1_2_7_28_1 doi: 10.1161/01.ATV.20.1.80 – volume: 154 start-page: 6492 year: 1995 ident: e_1_2_7_10_1 article-title: Platelet activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin‐dependent mechanism publication-title: J. Immunol. doi: 10.4049/jimmunol.154.12.6492 – ident: e_1_2_7_35_1 doi: 10.1038/sj.bjp.0703756 – volume: 72 start-page: 601 year: 1995 ident: e_1_2_7_16_1 article-title: Correlation of 133Xe clearance, blood flow and histology in the rat sponge model for angiogenesis publication-title: Lab. Invest. – ident: e_1_2_7_23_1 doi: 10.1006/mvre.1999.2217 – ident: e_1_2_7_36_1 doi: 10.1016/0014-2999(94)90068-X – ident: e_1_2_7_9_1 doi: 10.1172/JCI118142 – ident: e_1_2_7_25_1 doi: 10.1152/ajpregu.2001.280.4.R994 – volume: 34 start-page: 221 year: 1991 ident: e_1_2_7_2_1 article-title: UK74505, a novel and selective PAF antagonist, exhibits potent and long lasting activity in vivo publication-title: Agents Actions (Suppl.) – volume: 73 start-page: 503 year: 1992 ident: e_1_2_7_4_1 article-title: Effects of platelet activating factor (PAF) and other vasoconstrictors on a model of angiogenesis in the mouse publication-title: Int. J. Exp. Pathol. – ident: e_1_2_7_7_1 doi: 10.1093/carcin/14.7.1289 – ident: e_1_2_7_24_1 doi: 10.1016/S0167-0115(02)00070-8 – volume: 67 start-page: 519 year: 1992 ident: e_1_2_7_31_1 article-title: A simple, quantitative method for assessing angiogenesis and antiangiogenesis agents using reconstituted basement membrane, heparin and fibroblast growth factor publication-title: Lab. Invest. – ident: e_1_2_7_18_1 doi: 10.1016/S0163-7827(99)00016-8 – volume: 98 start-page: 719 year: 1932 ident: e_1_2_7_11_1 article-title: Spectrophotometric constants common hemoglobin derivatives in human, dog, and rabbit blood publication-title: J. Biol. Chem. – ident: e_1_2_7_34_1 doi: 10.4049/jimmunol.168.11.5798 – ident: e_1_2_7_17_1 doi: 10.1084/jem.187.11.1779 – volume: 162 start-page: 327 year: 1988 ident: e_1_2_7_5_1 article-title: Sponge implants as models publication-title: Method Immunol. – ident: e_1_2_7_29_1 doi: 10.1007/s00705-002-0903-6 – volume: 10 start-page: 251 year: 1994 ident: e_1_2_7_30_1 article-title: Pharmacological profile of UK‐74,505, a novel and selective PAF antagonist with potent and prolonged oral activity publication-title: J. Lipid Mediat. Cell Signal. – ident: e_1_2_7_14_1 doi: 10.1001/archsurg.1989.01410120068014 – ident: e_1_2_7_20_1 doi: 10.1096/fasebj.11.6.9194526 – ident: e_1_2_7_13_1 doi: 10.1038/nm0195-27 – ident: e_1_2_7_39_1 doi: 10.1074/jbc.270.14.7787 – ident: e_1_2_7_37_1 doi: 10.1016/S0022-2275(20)39691-7 – ident: e_1_2_7_21_1 doi: 10.1016/0006-291X(89)90032-6 – ident: e_1_2_7_27_1 doi: 10.1152/physrev.2000.80.4.1669 – reference: 15023858 - Br J Pharmacol. 2004 Apr;141(7):1085-6. doi: 10.1038/sj.bjp.0705728 |
SSID | ssj0014775 |
Score | 1.9336255 |
Snippet | To determine biological functions of platelet‐activating factor (PAF) in chronic inflammation, we have investigated the kinetics of angiogenesis, inflammatory... 1. To determine biological functions of platelet-activating factor (PAF) in chronic inflammation, we have investigated the kinetics of angiogenesis,... To determine biological functions of platelet-activating factor (PAF) in chronic inflammation, we have investigated the kinetics of angiogenesis, inflammatory... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1185 |
SubjectTerms | Acetylglucosaminidase Administration, Topical Animals Biological and medical sciences Blood Vessels - growth & development Blood Vessels - pathology chemokines Chemokines - metabolism Dihydropyridines - adverse effects Dihydropyridines - therapeutic use Fibroblasts - pathology Granulation Tissue - physiopathology Granuloma - chemically induced Granuloma - pathology growth factors Hemoglobins - chemistry Imidazoles - adverse effects Imidazoles - therapeutic use Implants, Experimental - adverse effects Inflammation - chemically induced Inflammation - physiopathology Inflammation - prevention & control Macrophages - pathology Medical sciences Mice Mice, Inbred BALB C Mice, Knockout Neovascularization Neovascularization, Pathologic - chemically induced Neovascularization, Pathologic - physiopathology Neovascularization, Pathologic - prevention & control Neutrophils - pathology Peroxidase Pharmacology. Drug treatments Platelet Activating Factor - administration & dosage Platelet Activating Factor - metabolism Platelet Activating Factor - pharmacokinetics Platelet Membrane Glycoproteins - antagonists & inhibitors Platelet Membrane Glycoproteins - deficiency Platelet Membrane Glycoproteins - genetics Polyurethanes - administration & dosage Polyurethanes - adverse effects Polyurethanes - chemistry Porifera - chemistry Receptors, G-Protein-Coupled - antagonists & inhibitors Receptors, G-Protein-Coupled - deficiency Receptors, G-Protein-Coupled - genetics Skin - blood supply Skin - pathology sponge implants |
Title | Sponge‐induced angiogenesis and inflammation in PAF receptor‐deficient mice (PAFR‐KO) |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1038%2Fsj.bjp.0705731 https://www.ncbi.nlm.nih.gov/pubmed/15023865 https://www.proquest.com/docview/217193242 https://www.proquest.com/docview/71799129 https://pubmed.ncbi.nlm.nih.gov/PMC1574894 |
Volume | 141 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1bb9MwFD6C7QUJIe6EQfEDGiDVG4ntOH1CLayqQIxorFLfLMd2SiuUBLI97N9znKTpKm5PkWPLin1un2P7OwAvJUat3Dq0b8QDFCNeTrO3mlOhnWbGCJE3yWA-n8azOf-4EIvubE7dHavc-MTGUdvS-H_kxwidPdbg0bvqB_VJo_zmapdB4ybse-Yyr9Ry0a-3Qi5lm8DA8yCGSbLhbGTJcb0-ytbVEeq7kCzciUm3K13j9ORtXos_Ac_fz09ex7VNYJrehTsdoiTjVgXuwQ1X3IfDtKWkvhqS8-0Nq3pIDkm6Jau-egDzr1VZLB3FpTkK2RJdLFfl0jvAVY0FS1ADUWnaC45YIOl4StBLugoX69Q6T0CB30d8VnvyGivP6Kcvbx7CfHpy_n5Gu1QLFMXBBE24EW6kZRTJ2OSRCzOjxcgaHnOrXZaEBiXHMnwTCWOFzIyHZjx2LpRWOsMewV5RFu4JkCyR2nA-ikPtuIssFj0HGrOMGYddB0A3k61Mx0Pu02F8V81-OEtUvVYoHNUJJ4BXffuqZeD4a8vBjuy2zQWGZJGMAjjYCFN1plqrXrECeNHXoo35jRNduPKyVtLT5iEwCuBxK_hrPXvME4sA5I5K9A08e_duTbH61rB4h8IT__AAho3y_GdsapLOeByLp_8cwgHc2p4segZ7Fz8v3XMETRfZoDGNAeyPJx8mU3xOTk7Ts19PihpL |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFD4a4wEkhLiTDTY_wACp3pbEjtMHhMal6ug2KtZKfQuO7XStIAlLJ9QfxX_kOGnSVdye9ujYcuyc2-fY_g7AM4FRK9EG7RvxAMWIl9B4XzLKpZG-UpwnZTKY45OgO2QfR3y0Bj_ruzD2WGXtE0tHrTNl_5HvIXS2WIN5b_Lv1CaNspurdQaNSit6Zv4DV2zF68P3KN7nntf5MHjXpYukAhRf7HMaMsVNWwrPE4FKPOPGSvK2VixgWpo4dBWO0Y_xiceV5iJWFoSwwBhXaGGUj_1eg-sYd_ftWk-MmvWdy4SoEiZY3kU3DGuOSD_cK6a78TTfRfviwndXYuCtXBYojqTKo_EnoPv7ec3LOLoMhJ07cHuBYMlBpXJ3Yc2k92CnX1Fgz1tksLzRVbTIDukvybHn92F4mmfp2NBJqlGpNJHpeJKNrcOdFFjQBDUelbS6UIkF0j_oEPTKJp9l51QbS3iB4yPf0MGRl1j5mfY-vXoAwyuRwkNYT7PUPAYSh0IqxtqBKw0znsai5Vzzte8rg107QOuPHakF77lNv_E1Kvff_TAqphEKJ1oIx4EXTfu8Yvz4a8utFdktm3OEADxsO7BZCzNauIYiahTZge2mFm3abtTI1GQXRSQsTR8CMQceVYK_1LPFWAF3QKyoRNPAsoWv1qSTs5I13OWWaIg50CqV5z9zi972uywI-MY_p7ANN7qD46Po6PCktwk3l6eansD67PzCPEXANou3SjMh8OWq7fIXz4tVpA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sponge-induced+angiogenesis+and+inflammation+in+PAF+receptor-deficient+mice+%28PAFR-KO%29&rft.jtitle=British+journal+of+pharmacology&rft.au=Ferreira%2C+M%C3%B4nica+A+N+D&rft.au=Barcelos%2C+Luc%C3%ADola+S&rft.au=Campos%2C+Paula+P&rft.au=Vasconcelos%2C+Anilton+C&rft.date=2004-04-01&rft.issn=0007-1188&rft.volume=141&rft.issue=7&rft.spage=1185&rft_id=info:doi/10.1038%2Fsj.bjp.0705731&rft_id=info%3Apmid%2F15023865&rft.externalDocID=15023865 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1188&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1188&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1188&client=summon |